<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04101240</url>
  </required_header>
  <id_info>
    <org_study_id>IMPACT (29BRC19.0013)</org_study_id>
    <nct_id>NCT04101240</nct_id>
  </id_info>
  <brief_title>Anemia and Red Blood Cells Transfusion in Oncological Surgery</brief_title>
  <acronym>IMPACT</acronym>
  <official_title>Impact of Perioperative Anemia and Red Blood Cells Transfusion on Post-operative Complications After Oncological Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oncologic patients experience anemia and anemia is associated with poor prognosis.
      Transfusion is associated with adverse events, and equipoise remains on the optimal
      transfusion strategy in oncologic patients in surgical setting. The primary objective of this
      study is to determine the impact of anemia and red blood cells (RBC) transfusion on
      post-operative complications and mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between 36 and 75% of oncologic patients experience anemia and anemia is associated with poor
      prognosis. Up to 40% of surgical oncologic patients receive red blood cells (RBC). However,
      transfusion is associated with adverse events, and equipoise remains on the optimal
      transfusion strategy in oncologic patients in surgical setting. The primary objective of this
      study is to determine the impact of anemia and red blood cells (RBC) transfusion on
      post-operative complications and mortality. This is a retrospective, single center study. All
      adults admitted to the intensive care unit (ICU) after oncologic surgery within the study
      period are eligible.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of mortality or any respiratory, cardiac, renal, thromboembolic, infectious and/or hemorrhagic post operative complications</measure>
    <time_frame>30 DAYS (hospital discharge)</time_frame>
    <description>mortality or any respiratory, cardiac, renal, thromboembolic, infectious and/or hemorrhagic post operative complications</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Anemia</condition>
  <condition>Surgery</condition>
  <condition>Oncology</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All adults admitted to the intensive care unit (ICU) after oncologic surgery from January
        2017 to December 2018 are eligible. The following types of surgery for cancer or metastasis
        resection with a high risk of bleeding are eligible: thoracic, abdominal, neurosurgery,
        gynecologic, urologic, otorhinolaryngology or spinal surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Surgery for cancer

          -  Admission to intensive care

        Exclusion Criteria:

          -  no consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile AUBRON, PU PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine Intensive Réanimation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cécile AUBRON, PU PH</last_name>
    <phone>+33298347181</phone>
    <email>cecile.aubron@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest, hôpital de la Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile AUBRON, PU-PH</last_name>
      <phone>+33298347181</phone>
      <email>cecile.aubron@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 23, 2019</study_first_submitted>
  <study_first_submitted_qc>September 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>September 23, 2019</last_update_submitted>
  <last_update_submitted_qc>September 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>red blood cells transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

